Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New information about effects of aging on the brain

New information about effects of aging on the brain

Targacept commences AZD3480 Phase 2b study in Alzheimer’s disease

Targacept commences AZD3480 Phase 2b study in Alzheimer’s disease

Art, drama and dance may benefit dementia sufferers

Art, drama and dance may benefit dementia sufferers

Alzheimer Society urges Liberal Government to make good on their healthcare commitments

Alzheimer Society urges Liberal Government to make good on their healthcare commitments

Hysterectomy increases brain iron levels in both men and women

Hysterectomy increases brain iron levels in both men and women

New insight into mechanisms of hippocampal rhythms

New insight into mechanisms of hippocampal rhythms

Alzheimer's may originate in a form similar to that of infectious prion diseases

Alzheimer's may originate in a form similar to that of infectious prion diseases

UCLA neuro-physicists discover optimal brain rhythm for changing synaptic strength

UCLA neuro-physicists discover optimal brain rhythm for changing synaptic strength

Complete Genomics, Scripps collaborate to unlock genetic secrets of lifelong health

Complete Genomics, Scripps collaborate to unlock genetic secrets of lifelong health

Researchers apply new approach to take a close look at amyloid plaque formation

Researchers apply new approach to take a close look at amyloid plaque formation

Viewpoints: Mixing Obama and Ryan's plans, cancer rationing and stalling federal aid

Viewpoints: Mixing Obama and Ryan's plans, cancer rationing and stalling federal aid

Strong connection between preterm birth and risk of epilepsy

Strong connection between preterm birth and risk of epilepsy

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

OCC applauds political parties for introducing policies to support caregivers

OCC applauds political parties for introducing policies to support caregivers

Amorfix achieves 85% specificity and sensitivity with EP-AD CSF Diagnostic Test for AD

Amorfix achieves 85% specificity and sensitivity with EP-AD CSF Diagnostic Test for AD

Experts to discuss issues related to stroke at Canadian Stroke Congress

Experts to discuss issues related to stroke at Canadian Stroke Congress

Hospital readmission rates reflect problem in addressing hospital failures

Hospital readmission rates reflect problem in addressing hospital failures

GSA, NAM select 16 reporters for MetLife Foundation Journalists in Aging Fellows Program

GSA, NAM select 16 reporters for MetLife Foundation Journalists in Aging Fellows Program

Researchers discover kibra protein controls sculpting of brain circuitry

Researchers discover kibra protein controls sculpting of brain circuitry

Prehypertension may increase risk of stroke

Prehypertension may increase risk of stroke

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.